Get the Stockscreener App
6.30
1.61%
0.10
After Hours:
6.30
Nyxoah Sa stock is traded at $6.30, with a volume of 48,475.
It is up +1.61% in the last 24 hours and up +0.96% over the past month.
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.
See More
Previous Close:
$6.20
Open:
$6.27
24h Volume:
48,475
Relative Volume:
0.36
Market Cap:
$228.31M
Revenue:
$4.71M
Net Income/Loss:
$-46.77M
P/E Ratio:
-3.7518
EPS:
-1.6792
Net Cash Flow:
$-60.34M
1W Performance:
+3.28%
1M Performance:
+0.96%
6M Performance:
-33.61%
1Y Performance:
-26.06%
1-Day Range:
$6.13
$6.36
1-Week Range:
$6.03
$6.66
52-Week Range:
$5.55
$12.21
Nyxoah Sa Stock (NYXH) Company Profile
Name
Nyxoah Sa
Sector
Industry
Phone
-
Address
-
Compare NYXH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NYXH
Nyxoah Sa
|
6.30 | 228.31M | 4.71M | -46.77M | -60.34M | -1.6792 |
|
ISRG
Intuitive Surgical Inc
|
536.51 | 189.75B | 8.71B | 2.48B | 1.75B | 6.82 |
|
ALC
Alcon Inc
|
95.75 | 48.62B | 9.91B | 1.02B | 665.00M | 2.05 |
|
BDX
Becton Dickinson Co
|
167.22 | 48.37B | 20.87B | 1.50B | 2.59B | 5.24 |
|
RMD
Resmed Inc
|
245.04 | 35.18B | 5.02B | 1.31B | 1.56B | 8.91 |
|
COO
The Cooper Companies, Inc.
|
82.27 | 16.46B | 3.90B | 392.30M | 288.10M | 1.95 |
Nyxoah Sa Stock (NYXH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-31-23 | Initiated | H.C. Wainwright | Buy |
| Jul-19-23 | Initiated | Robert W. Baird | Neutral |
| Apr-21-22 | Initiated | Oppenheimer | Outperform |
| Apr-06-22 | Initiated | Wolfe Research | Peer Perform |
| Dec-21-21 | Resumed | Cantor Fitzgerald | Overweight |
| Jul-28-21 | Initiated | Cantor Fitzgerald | Overweight |
View All
Nyxoah Sa Stock (NYXH) Latest News
Publication relating to transparency notifications - Stock Titan
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A.NYXH - Bluefield Daily Telegraph
Nyxoah SA Schedules Shareholders’ Meetings for June 2025 - TipRanks
Invitation to attend the annual and the extraordinary shareholders’ meetings of the Company to be held on June 11, 2025 - GlobeNewswire Inc.
Nyxoah to Release First Quarter 2025 Financial Results on May 14, 2025 - The Manila Times
Renaissance Technologies LLC Purchases Shares of 23,400 Nyxoah S.A. (NASDAQ:NYXH) - Defense World
Long Term Trading Analysis for (NYXH) - news.stocktradersdaily.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Nyxoah S.A.NYXH - Bluefield Daily Telegraph
Nyxoah S.A. (NASDAQ:NYXH) Shares Bought by Geode Capital Management LLC - Defense World
LPL Financial LLC Buys Shares of 12,700 Nyxoah S.A. (NASDAQ:NYXH) - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Stifel cuts Nyxoah stock price target to $14, maintains Buy rating - Investing.com Canada
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of OSI Systems, Inc. - GlobeNewswire Inc.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HealthEquity, Inc. - GlobeNewswire Inc.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - GlobeNewswire Inc.
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Nyxoah S.A. (NYXH) and Encourages Shareholders to Learn More About the Investigation - markets.businessinsider.com
Nyxoah S.A. (NYXH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - markets.businessinsider.com
Bronstein, Gewirtz & Grossman, LLC Encourages Nyxoah S.A. (NYXH) Shareholders to Inquire about Securities Investigation - markets.businessinsider.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating Nyxoah S.A. (NYXH) And Encourages Investors to Connect - markets.businessinsider.com
Nyxoah Announces Conditional Issuance of 5 Million Shares - TipRanks
Nyxoah Expands ATM Program: 5.66M Total Shares Now Available for Market Sale - Stock Titan
Conditional Issuance of Shares - The Manila Times
Nyxoah S.A. (NYXH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Nyxoah S.A. (NYXH) And Encourages Stockholders to Connect - markets.businessinsider.com
Nyxoah S.A. (NYXH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - markets.businessinsider.com
Nyxoah’s Final Hurdle for FDA Approval of Genio Neurostimulator for Sleep Apnea - sleepreviewmag.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Nyxoah S.A. (NYXH) and Encourages Stockholders to Learn More About the Investigation - markets.businessinsider.com
Bronstein, Gewirtz & Grossman, LLC Encourages Nyxoah S.A. (NYXH) Investors to Inquire about Securities Investigation - ACCESS Newswire
Nyxoah Expects to Meet Final FDA Requirements for Sleep Apnea Treatment Device Approval in Q2 - MarketScreener
Nyxoah Expects Q2 Approval of Genio System from US FDA - MarketScreener
Nyxoah Provides Update on FDA Approvable Letter for Genio System - The Manila Times
Nyxoah Provides Update On FDA Approvable Letter For Genio System - MarketScreener
FDA Signals Green Light for Revolutionary Sleep Apnea TreatmentJust One Step Away - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Nyxoah S.A. (NYXH) And Encourages Investors to Reach Out - markets.businessinsider.com
NYXH Investors Have Opportunity to Join Nyxoah S.A. Fraud Invest - GuruFocus
NYXH Investors Have Opportunity to Join Nyxoah S.A. Fraud Investigation with the Schall Law Firm - Morningstar
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - GlobeNewswire Inc.
Nyxoah S.A. Investors: Company Investigated by the Portnoy Law Firm - GlobeNewswire
Oppenheimer maintains $13 target on Nyxoah shares post-FDA talks By Investing.com - Investing.com South Africa
Oppenheimer maintains $13 target on Nyxoah shares post-FDA talks - Investing.com
Nyxoah Sa Stock (NYXH) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.40%
0.78%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):